Atlas Trials

A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients

Clinical trial NCT04516655 · UNKNOWN

Trial details

NCT number
NCT04516655
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Central Nervous System Lymphoma
Start date
2020-09-01
Primary completion
2021-09-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.